Academic studies have associated Part D coverage with decreases in hospital admissions and over $2 billion in savings due to improved drug adherence among patients with congestive heart failure. The government doesnâ€™t directly negotiate drug prices in Part D of Medicare, nor does it set the cost of the benefit.   Instead, health plans and PBMs negotiate prices with drug manufacturers and then compete with one another based on price and quality, for market share.   As a result, Part D is the rare federal program that has come in  . 